1
|
Takei S, Teramoto K, Fujimura J, Fujiwara M, Suzuki M, Fukui Y, Sekiguchi Y, Kawakami T, Chonan M, Wakita M, Horiuchi Y, Miida T, Naito T, Kirikae T, Tada T, Tabe Y. Isolation and identification of Wickerhamiella tropicalis from blood culture by MALDI-MS. Front Cell Infect Microbiol 2024; 14:1361432. [PMID: 38510957 PMCID: PMC10953818 DOI: 10.3389/fcimb.2024.1361432] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2023] [Accepted: 02/20/2024] [Indexed: 03/22/2024] Open
Abstract
Wickerhamiella is a genus of budding yeast that is mainly isolated from environmental samples, and 40 species have been detected. The yeast isolated from human clinical samples usually only contain three species: W. infanticola, W. pararugosa and W. sorbophila. In this study, we isolated W. tropicalis from a blood sample of a six-year-old female with a history of B-cell precursor lymphoblastic leukemia in Japan in 2022. Though the strain was morphologically identified as Candida species by routine microbiological examinations, it was subsequently identified as W. tropicalis by sequencing the internal transcribed spacer (ITS) of ribosomal DNA (rDNA). The isolate had amino acid substitutions in ERG11 and FKS1 associated with azole and echinocandin resistance, respectively, in Candida species and showed intermediate-resistant to fluconazole and micafungin. The patient was successfully treated with micafungin. Furthermore, matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) detected three novel peaks that are specific for W. tropicalis, indicating that MALDI-MS analysis is useful for rapid detection of Wickerhamiella species in routine microbiological examinations.
Collapse
Affiliation(s)
- Satomi Takei
- Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan
- Department of MALDI-TOF MS Practical Application Research, Juntendo University Graduate School of Medicine, Tokyo, Japan
| | - Kanae Teramoto
- Department of MALDI-TOF MS Practical Application Research, Juntendo University Graduate School of Medicine, Tokyo, Japan
- Analytical & Measurement Instruments Division, Shimadzu Corporation, Kyoto, Japan
| | - Junya Fujimura
- Department of Pediatrics, Juntendo University Graduate School of Medicine, Tokyo, Japan
| | - Megumi Fujiwara
- Department of Pediatrics, Juntendo University Graduate School of Medicine, Tokyo, Japan
| | - Mai Suzuki
- Department of General Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan
| | - Yukiko Fukui
- Department of General Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan
| | - Yuji Sekiguchi
- Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki, Japan
| | - Takaaki Kawakami
- Department of Clinical Laboratory, Juntendo University Hospital, Tokyo, Japan
| | - Masayoshi Chonan
- Department of Clinical Laboratory, Juntendo University Hospital, Tokyo, Japan
| | - Mitsuru Wakita
- Department of Clinical Laboratory, Juntendo University Hospital, Tokyo, Japan
| | - Yuki Horiuchi
- Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan
| | - Takashi Miida
- Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan
| | - Toshio Naito
- Department of MALDI-TOF MS Practical Application Research, Juntendo University Graduate School of Medicine, Tokyo, Japan
- Department of General Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan
| | - Teruo Kirikae
- Department of MALDI-TOF MS Practical Application Research, Juntendo University Graduate School of Medicine, Tokyo, Japan
- Department of Microbiome Research, Juntendo University Graduate School of Medicine, Tokyo, Japan
| | - Tatsuya Tada
- Department of Microbiology, Juntendo University Graduate School of Medicine, Tokyo, Japan
| | - Yoko Tabe
- Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan
- Department of MALDI-TOF MS Practical Application Research, Juntendo University Graduate School of Medicine, Tokyo, Japan
| |
Collapse
|
2
|
İlhan B, Vural C, Gürhan C, Vural C, Veral A, Wilder-Smith P, Özdemir G, Güneri P. Real-Time PCR Detection of Candida Species in Biopsy Samples from Non-Smokers with Oral Dysplasia and Oral Squamous Cell Cancer: A Retrospective Archive Study. Cancers (Basel) 2023; 15:5251. [PMID: 37958424 PMCID: PMC10649242 DOI: 10.3390/cancers15215251] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2023] [Revised: 10/29/2023] [Accepted: 10/30/2023] [Indexed: 11/15/2023] Open
Abstract
The impact of Candida sp. in the development of oral cancer remains uncertain and requires sensitive analytical approaches for clarification. Given the invasive capabilities of these microorganisms in penetrating and invading host tissues through hyphal invasion, this study sought to detect the presence of five Candida sp. in oral biopsy tissue samples from non-smoker patients. Samples were obtained from patients at varying stages of oral carcinogenesis, including dysplasia, carcinoma in situ, OSCC, and histologically benign lesions, and analyzed using Real-Time PCR. Oral tissue samples from 80 patients (46 males and 34 females) were included. Significantly higher C. albicans presence was detected in the mild/moderate dysplasia group compared to the healthy (p = 0.001), carcinoma in situ (p = 0.031) and OSCC groups (p = 0.000). Similarly, C. tropicalis carriage was higher in tissues with mild/moderate dysplasia compared to healthy (p = 0.004) and carcinoma in situ (p = 0.019). Our results showed a significant increase in the presence of C. albicans and C. tropicalis within the mild/moderate dysplasia group compared to other cohorts. Coexistence of these two microorganisms was observed, suggesting a potential transition from a commensal state to an opportunistic pathogen, which could be particularly linked to the onset of oral neoplasia.
Collapse
Affiliation(s)
- Betül İlhan
- Department of Oral & Maxillofacial Radiology, Faculty of Dentistry, Ege University, 35040 İzmir, Türkiye; (B.İ.); (P.G.)
| | - Caner Vural
- Molecular Biology Section, Department of Biology, Faculty of Science, Pamukkale University, 20160 Denizli, Türkiye;
| | - Ceyda Gürhan
- Department of Oral & Maxillofacial Radiology, Faculty of Dentistry, Muğla Sıtkı Koçman University, 48000 Muğla, Türkiye;
| | - Cansu Vural
- Basic and Industrial Microbiology Section, Department of Biology, Ege University, 35040 İzmir, Türkiye; (C.V.); (G.Ö.)
| | - Ali Veral
- Department of Medical Pathology, Faculty of Medicine, Ege University, 35040 İzmir, Türkiye;
| | - Petra Wilder-Smith
- Beckman Laser Institute, University of California Irvine, Irvine, CA 92697, USA
| | - Güven Özdemir
- Basic and Industrial Microbiology Section, Department of Biology, Ege University, 35040 İzmir, Türkiye; (C.V.); (G.Ö.)
| | - Pelin Güneri
- Department of Oral & Maxillofacial Radiology, Faculty of Dentistry, Ege University, 35040 İzmir, Türkiye; (B.İ.); (P.G.)
| |
Collapse
|
3
|
Saltović E, Mijandrušić-Sinčić B, Braut A, Škrobonja I, Sever E, Glažar I, Pezelj-Ribarić S, Muhvić-Urek M. Absence of Oral Opportunistic Infections in Patients with Inflammatory Bowel Disease Receiving Anti-TNF-α and Anti-Integrin-α 4β 7 Therapy. Dent J (Basel) 2022; 10:dj10030032. [PMID: 35323234 PMCID: PMC8947472 DOI: 10.3390/dj10030032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2021] [Revised: 02/16/2022] [Accepted: 02/21/2022] [Indexed: 02/04/2023] Open
Abstract
Biological therapy of inflammatory bowel disease (IBD) carries an increased risk for the development of opportunistic infections due to immunomodulation. The aim of this study was to determine the prevalence and types of oral infections in IBD patients treated with biological (anti-TNF-α and anti-integrin-α4β7) and conventional medication protocols. The study included 20 IBD patients receiving anti-TNF-α therapy, 20 IBD patients receiving anti-integrin-α4β7 therapy and 20 IBD patients without immunomodulatory therapy. Participants completed questionnaires on medical information, oral lesions and symptoms. For each patient, clinical examination and a salivary flow rate test were performed, followed by a swab of the oral mucosa. The swab samples were cultured to identify Candida spp. and oral bacteria. No bacterial opportunistic infections were detected. Candidiasis was detected in four participants, with no significant difference between groups (p = 0.765). Hyposalivation was most common in the anti-TNF-α group, with a significant difference between groups (p = 0.036). There were no significant differences between groups in self-reported oral mucosal lesions and symptoms (p > 0.05), or in the distribution of oral mucosal lesions (p > 0.05). This study suggests that IBD patients receiving biological therapy are at no greater risk of developing oral opportunistic infections than IBD patients not receiving immunomodulatory therapy.
Collapse
Affiliation(s)
- Ema Saltović
- Clinic of Dental Medicine, Clinical Hospital Center Rijeka, Krešimirova 40, 51000 Rijeka, Croatia; (E.S.); (A.B.); (I.G.); (S.P.-R.)
| | - Brankica Mijandrušić-Sinčić
- Clinic of Internal Medicine, Clinical Hospital Center Rijeka, Krešimirova 42, 51000 Rijeka, Croatia;
- Department of Internal Medicine, Faculty of Medicine, University of Rijeka, Braće Branchetta 20/1, 51000 Rijeka, Croatia
| | - Alen Braut
- Clinic of Dental Medicine, Clinical Hospital Center Rijeka, Krešimirova 40, 51000 Rijeka, Croatia; (E.S.); (A.B.); (I.G.); (S.P.-R.)
- Department of Restorative Dentistry and Endodontics, Faculty of Dental Medicine, University of Rijeka, Krešimirova 40, 51000 Rijeka, Croatia
| | - Ivana Škrobonja
- Clinical Department for Clinical Microbiology, Clinical Hospital Center Rijeka, Krešimirova 42, 51000 Rijeka, Croatia;
| | - Ella Sever
- Department of Oral Medicine and Periodontology, Faculty of Dental Medicine, University of Rijeka, Krešimirova 40, 51000 Rijeka, Croatia;
| | - Irena Glažar
- Clinic of Dental Medicine, Clinical Hospital Center Rijeka, Krešimirova 40, 51000 Rijeka, Croatia; (E.S.); (A.B.); (I.G.); (S.P.-R.)
- Department of Oral Medicine and Periodontology, Faculty of Dental Medicine, University of Rijeka, Krešimirova 40, 51000 Rijeka, Croatia;
| | - Sonja Pezelj-Ribarić
- Clinic of Dental Medicine, Clinical Hospital Center Rijeka, Krešimirova 40, 51000 Rijeka, Croatia; (E.S.); (A.B.); (I.G.); (S.P.-R.)
- Department of Oral Medicine and Periodontology, Faculty of Dental Medicine, University of Rijeka, Krešimirova 40, 51000 Rijeka, Croatia;
- Department of Dental Medicine, Faculty of Dental Medicine and Health, Josip Juraj Strossmayer University of Osijek, Crkvena 21, 31000 Osijek, Croatia
| | - Miranda Muhvić-Urek
- Clinic of Dental Medicine, Clinical Hospital Center Rijeka, Krešimirova 40, 51000 Rijeka, Croatia; (E.S.); (A.B.); (I.G.); (S.P.-R.)
- Department of Oral Medicine and Periodontology, Faculty of Dental Medicine, University of Rijeka, Krešimirova 40, 51000 Rijeka, Croatia;
- Correspondence:
| |
Collapse
|
4
|
Mendonça A, Santos H, Franco-Duarte R, Sampaio P. Fungal infections diagnosis - Past, present and future. Res Microbiol 2022; 173:103915. [PMID: 34863883 PMCID: PMC8634697 DOI: 10.1016/j.resmic.2021.103915] [Citation(s) in RCA: 25] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2021] [Revised: 11/19/2021] [Accepted: 11/26/2021] [Indexed: 01/07/2023]
Abstract
Despite the scientific advances observed in the recent decades and the emergence of new methodologies, the diagnosis of systemic fungal infections persists as a problematic issue. Fungal cultivation, the standard method that allows a proven diagnosis, has numerous disadvantages, as low sensitivity (only 50% of the patients present positive fungal cultures), and long growth time. These are factors that delay the patient's treatment and, consequently, lead to higher hospital costs. To improve the accuracy and quickness of fungal infections diagnosis, several new methodologies attempt to be implemented in clinical microbiology laboratories. Most of these innovative methods are independent of pathogen isolation, which means that the diagnosis goes from being considered proven to probable. In spite of the advantage of being culture-independent, the majority of the methods lack standardization. PCR-based methods are becoming more and more commonly used, which has earned them an important place in hospital laboratories. This can be perceived now, as PCR-based methodologies have proved to be an essential tool fighting against the COVID-19 pandemic. This review aims to go through the main steps of the diagnosis for systemic fungal infection, from diagnostic classifications, through methodologies considered as "gold standard", to the molecular methods currently used, and finally mentioning some of the more futuristic approaches.
Collapse
|
5
|
Huseynov RM, Javadov SS, Osmanov A, Khasiyev S, Valiyeva SR, Almammadova E, Denning DW. The burden of serious fungal infections in Azerbaijan. Ther Adv Infect Dis 2021; 8:20499361211043969. [PMID: 34497715 PMCID: PMC8419541 DOI: 10.1177/20499361211043969] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2021] [Accepted: 08/17/2021] [Indexed: 11/16/2022] Open
Abstract
Background: Azerbaijan is an upper middle-income country in South Caucasus with an area of 86,600 km2 and a total population of 10 million people and gross domestic product of US $4480 per capita. The aim of this research is to estimate fungal infection burden and highlight the problem at national and international levels. Methods: Fungal infection burden was estimated using data from epidemiological papers and population at risk and LIFE (Leading International Fungal Education) modelling. Results: The number of people living with human immunodeficiency virus (PLHIV) in 2018 was 6193, 29% of them not receiving antiretroviral therapy. Based on 90% and 20% rates of oral and oesophageal candidiasis in patients with CD4 cell count <200 µl–1 we estimate 808 and 579 patients with oral and oesophageal candidiasis, respectively. The annual incidences of cryptococcal meningitis and Pneumocystis pneumonia are 5 and 55 cases, respectively. We estimated 2307 cases of chronic pulmonary aspergillosis (CPA), 4927 patients with allergic bronchopulmonary aspergillosis (ABPA), and 6504 with severe asthma with fungal sensitization (SAFS). Using data on chronic obstructive pulmonary diseases (COPD), lung cancer, acute myeloid leukaemia rates, and number of transplantations, we estimated 693 cases of invasive aspergillosis following these conditions. Using a low-European rate for invasive candidiasis, we estimated 499 and 75 patients with candidemia and intra-abdominal candidiasis respectively. The number of adult women (15–55 years) in Azerbaijan is ~2,658,000, so it was estimated that 159,490 women suffer from recurrent vulvovaginal candidiasis (rVVC). Discussion: In total, the estimated number of people suffering from fungal diseases in Azerbaijan is 225,974 (2.3% of the population). However, the fungal rate is underestimated due to lack of epidemiological data. The most imminent need is improvement in diagnostic capabilities. This aim should be achieved via establishing a reference laboratory and equipping major clinical centers with essential diagnostics assays.
Collapse
Affiliation(s)
- Ravil M Huseynov
- The Department of Medical Microbiology and Immunology, Azerbaijan Medical University, Mardanov Qardashlari 98, Baku, Azerbaijan
| | - Samir S Javadov
- The Department of Medical Microbiology and Immunology, Azerbaijan Medical University, Baku, Azerbaijan
| | - Ali Osmanov
- Global Action Fund for Fungal Infections, Geneva, Switzerland
| | - Shahin Khasiyev
- The Department of Informatics and Statistics, Ministry of Health of Azerbaijan Republic, Baku, Azerbaijan
| | - Samira R Valiyeva
- Republican Centre for Combating AIDS, Ministry of Health of Azerbaijan Republic, Baku, Azerbaijan
| | - Esmira Almammadova
- Republican Centre for Combating AIDS, Ministry of Health of Azerbaijan Republic, Baku, Azerbaijan
| | - David W Denning
- Global Action Fund for Fungal Infections, Geneva, Switzerland
| |
Collapse
|
6
|
Moreno-Martínez AE, Gómez-Molero E, Sánchez-Virosta P, Dekker HL, de Boer A, Eraso E, Bader O, de Groot PWJ. High Biofilm Formation of Non-Smooth Candida parapsilosis Correlates with Increased Incorporation of GPI-Modified Wall Adhesins. Pathogens 2021; 10:pathogens10040493. [PMID: 33921809 PMCID: PMC8073168 DOI: 10.3390/pathogens10040493] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2021] [Revised: 04/15/2021] [Accepted: 04/16/2021] [Indexed: 11/16/2022] Open
Abstract
Candida parapsilosis is among the most frequent causes of candidiasis. Clinical isolates of this species show large variations in colony morphotype, ranging from round and smooth to a variety of non-smooth irregular colony shapes. A non-smooth appearance is related to increased formation of pseudohyphae, higher capacity to form biofilms on abiotic surfaces, and invading agar. Here, we present a comprehensive study of the cell wall proteome of C. parapsilosis reference strain CDC317 and seven clinical isolates under planktonic and sessile conditions. This analysis resulted in the identification of 40 wall proteins, most of them homologs of known Candida albicans cell wall proteins, such as Gas, Crh, Bgl2, Cht2, Ecm33, Sap, Sod, Plb, Pir, Pga30, Pga59, and adhesin family members. Comparative analysis of exponentially growing and stationary phase planktonic cultures of CDC317 at 30 °C and 37 °C revealed only minor variations. However, comparison of smooth isolates to non-smooth isolates with high biofilm formation capacity showed an increase in abundance and diversity of putative wall adhesins from Als, Iff/Hyr, and Hwp families in the latter. This difference depended more strongly on strain phenotype than on the growth conditions, as it was observed in planktonic as well as biofilm cells. Thus, in the set of isolates analyzed, the high biofilm formation capacity of non-smooth C. parapsilosis isolates with elongated cellular phenotypes correlates with the increased surface expression of putative wall adhesins in accordance with their proposed cellular function.
Collapse
Affiliation(s)
- Ana Esther Moreno-Martínez
- Albacete Regional Center for Biomedical Research, Castilla—La Mancha Science & Technology Park, University of Castilla-La Mancha, 02008 Albacete, Spain; (A.E.M.-M.); (E.G.-M.); (P.S.-V.); (A.d.B.)
| | - Emilia Gómez-Molero
- Albacete Regional Center for Biomedical Research, Castilla—La Mancha Science & Technology Park, University of Castilla-La Mancha, 02008 Albacete, Spain; (A.E.M.-M.); (E.G.-M.); (P.S.-V.); (A.d.B.)
- Institute for Medical Microbiology, University Medical Center Göttingen, Kreuzbergring 57, 37075 Göttingen, Germany
| | - Pablo Sánchez-Virosta
- Albacete Regional Center for Biomedical Research, Castilla—La Mancha Science & Technology Park, University of Castilla-La Mancha, 02008 Albacete, Spain; (A.E.M.-M.); (E.G.-M.); (P.S.-V.); (A.d.B.)
| | - Henk L. Dekker
- Mass Spectrometry of Biomolecules, Swammerdam Institute for Life Sciences, University of Amsterdam, 1098 XH Amsterdam, The Netherlands;
| | - Albert de Boer
- Albacete Regional Center for Biomedical Research, Castilla—La Mancha Science & Technology Park, University of Castilla-La Mancha, 02008 Albacete, Spain; (A.E.M.-M.); (E.G.-M.); (P.S.-V.); (A.d.B.)
| | - Elena Eraso
- Department of Immunology, Microbiology and Parasitology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48940 Bilbao, Spain;
| | - Oliver Bader
- Institute for Medical Microbiology, University Medical Center Göttingen, Kreuzbergring 57, 37075 Göttingen, Germany
- Correspondence: (O.B.); (P.W.J.d.G.)
| | - Piet W. J. de Groot
- Albacete Regional Center for Biomedical Research, Castilla—La Mancha Science & Technology Park, University of Castilla-La Mancha, 02008 Albacete, Spain; (A.E.M.-M.); (E.G.-M.); (P.S.-V.); (A.d.B.)
- Correspondence: (O.B.); (P.W.J.d.G.)
| |
Collapse
|
7
|
Pandey AK, Kumar M, Kumari S, Kumari P, Yusuf F, Jakeer S, Naz S, Chandna P, Bhatnagar I, Gaur NA. Evaluation of divergent yeast genera for fermentation-associated stresses and identification of a robust sugarcane distillery waste isolate Saccharomyces cerevisiae NGY10 for lignocellulosic ethanol production in SHF and SSF. BIOTECHNOLOGY FOR BIOFUELS 2019; 12:40. [PMID: 30858877 PMCID: PMC6391804 DOI: 10.1186/s13068-019-1379-x] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 10/01/2018] [Accepted: 02/15/2019] [Indexed: 06/09/2023]
Abstract
BACKGROUND Lignocellulosic hydrolysates contain a mixture of hexose (C6)/pentose (C5) sugars and pretreatment-generated inhibitors (furans, weak acids and phenolics). Therefore, robust yeast isolates with characteristics of C6/C5 fermentation and tolerance to pretreatment-derived inhibitors are pre-requisite for efficient lignocellulosic material based biorefineries. Moreover, use of thermotolerant yeast isolates will further reduce cooling cost, contamination during fermentation, and required for developing simultaneous saccharification and fermentation (SSF), simultaneous saccharification and co-fermentation (SScF), and consolidated bio-processing (CBP) strategies. RESULTS In this study, we evaluated thirty-five yeast isolates (belonging to six genera including Saccharomyces, Kluyveromyces, Candida, Scheffersomyces, Ogatea and Wickerhamomyces) for pretreatment-generated inhibitors {furfural, 5-hydroxymethyl furfural (5-HMF) and acetic acid} and thermotolerant phenotypes along with the fermentation performances at 40 °C. Among them, a sugarcane distillery waste isolate, Saccharomyces cerevisiae NGY10 produced maximum 49.77 ± 0.34 g/l and 46.81 ± 21.98 g/l ethanol with the efficiency of 97.39% and 93.54% at 30 °C and 40 °C, respectively, in 24 h using glucose as a carbon source. Furthermore, isolate NGY10 produced 12.25 ± 0.09 g/l and 7.18 ± 0.14 g/l of ethanol with 92.81% and 91.58% efficiency via SHF, and 30.22 g/l and 25.77 g/l ethanol with 86.43% and 73.29% efficiency via SSF using acid- and alkali-pretreated rice straw as carbon sources, respectively, at 40 °C. In addition, isolate NGY10 also produced 92.31 ± 3.39 g/l (11.7% v/v) and 33.66 ± 1.04 g/l (4.26% v/v) ethanol at 40 °C with the yields of 81.49% and 73.87% in the presence of 30% w/v glucose or 4× concentrated acid-pretreated rice straw hydrolysate, respectively. Moreover, isolate NGY10 displayed furfural- (1.5 g/l), 5-HMF (3.0 g/l), acetic acid- (0.2% v/v) and ethanol-(10.0% v/v) tolerant phenotypes. CONCLUSION A sugarcane distillery waste isolate NGY10 demonstrated high potential for ethanol production, C5 metabolic engineering and developing strategies for SSF, SScF and CBP.
Collapse
Affiliation(s)
- Ajay Kumar Pandey
- Yeast Biofuel Group, DBT-ICGEB Center for Advanced Bioenergy Research, International Center for Genetic Engineering and Biotechnology (ICGEB), New Delhi, 110067 India
| | - Mohit Kumar
- Yeast Biofuel Group, DBT-ICGEB Center for Advanced Bioenergy Research, International Center for Genetic Engineering and Biotechnology (ICGEB), New Delhi, 110067 India
| | - Sonam Kumari
- Yeast Biofuel Group, DBT-ICGEB Center for Advanced Bioenergy Research, International Center for Genetic Engineering and Biotechnology (ICGEB), New Delhi, 110067 India
| | - Priya Kumari
- Yeast Biofuel Group, DBT-ICGEB Center for Advanced Bioenergy Research, International Center for Genetic Engineering and Biotechnology (ICGEB), New Delhi, 110067 India
| | - Farnaz Yusuf
- Yeast Biofuel Group, DBT-ICGEB Center for Advanced Bioenergy Research, International Center for Genetic Engineering and Biotechnology (ICGEB), New Delhi, 110067 India
| | - Shaik Jakeer
- Yeast Biofuel Group, DBT-ICGEB Center for Advanced Bioenergy Research, International Center for Genetic Engineering and Biotechnology (ICGEB), New Delhi, 110067 India
| | - Sumera Naz
- Yeast Biofuel Group, DBT-ICGEB Center for Advanced Bioenergy Research, International Center for Genetic Engineering and Biotechnology (ICGEB), New Delhi, 110067 India
| | - Piyush Chandna
- Yeast Biofuel Group, DBT-ICGEB Center for Advanced Bioenergy Research, International Center for Genetic Engineering and Biotechnology (ICGEB), New Delhi, 110067 India
| | - Ishita Bhatnagar
- Yeast Biofuel Group, DBT-ICGEB Center for Advanced Bioenergy Research, International Center for Genetic Engineering and Biotechnology (ICGEB), New Delhi, 110067 India
| | - Naseem A. Gaur
- Yeast Biofuel Group, DBT-ICGEB Center for Advanced Bioenergy Research, International Center for Genetic Engineering and Biotechnology (ICGEB), New Delhi, 110067 India
| |
Collapse
|
8
|
De-La-Torre J, Quindós G, Marcos-Arias C, Marichalar-Mendia X, Gainza ML, Eraso E, Acha-Sagredo A, Aguirre-Urizar JM. Oral Candida colonization in patients with chronic periodontitis. Is there any relationship? Rev Iberoam Micol 2018; 35:134-139. [PMID: 30082174 DOI: 10.1016/j.riam.2018.03.005] [Citation(s) in RCA: 31] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2017] [Revised: 02/13/2018] [Accepted: 03/14/2018] [Indexed: 02/07/2023] Open
Abstract
BACKGROUND Candida can be implicated in the pathology of chronic periodontitis. AIMS To analyze the oral Candida carriage in patients suffering from chronic periodontitis (CP) and its correlation with the severity of this condition. METHODS Microbiological samples were taken from 155 patients using the oral rinse (OR) technique and by using paper points in the periodontal pockets (GPP). These patients were divided into 3 groups: 89 patients without CP (control), 47 with moderate CP, and 19 with severe CP. Samples were cultured in a Candida chromogenic agar for Candida. Species were identified by microbiological and molecular methods. RESULTS Candida was isolated in the OR of 45 (50.6%), 21 (44.7%), and 11 (57.9%) patients, respectively, and in the GPP of 32 (36%), 14 (29.2%), and 10 (42.6%) patients from the control, moderate CP and severe CP groups, respectively. Candida was isolated more frequently and in a greater burden in OR than in GPP (p<0.01). Candida albicans was the most prevalent species. GPP of patients with CP had poor fungal biodiversity (p<0.01). CONCLUSIONS Colonization by Candida was present in the samples of patients without CP, and with both moderate and severe CP. Nonetheless, patients with severe CP had a higher rate of Candida colonization, especially by C. albicans.
Collapse
Affiliation(s)
- Janire De-La-Torre
- Department of Immunology, Microbiology and Parasitology, Unidad de formación e investigación multidisciplinar "Microbios y Salud" (UFI 11/25), Faculty of Medicine and Dentistry, University of the Basque Country/Euskal Herriko Unibertsitatea, Leioa, Spain; Department of Stomatology II, Unidad de formación e investigación multidisciplinar "Microbios y Salud" (UFI 11/25), Faculty of Medicine and Dentistry, University of the Basque Country/Euskal Herriko Unibertsitatea, Leioa, Spain.
| | - Guillermo Quindós
- Department of Immunology, Microbiology and Parasitology, Unidad de formación e investigación multidisciplinar "Microbios y Salud" (UFI 11/25), Faculty of Medicine and Dentistry, University of the Basque Country/Euskal Herriko Unibertsitatea, Leioa, Spain
| | - Cristina Marcos-Arias
- Department of Immunology, Microbiology and Parasitology, Unidad de formación e investigación multidisciplinar "Microbios y Salud" (UFI 11/25), Faculty of Medicine and Dentistry, University of the Basque Country/Euskal Herriko Unibertsitatea, Leioa, Spain
| | - Xabier Marichalar-Mendia
- Department of Stomatology II, Unidad de formación e investigación multidisciplinar "Microbios y Salud" (UFI 11/25), Faculty of Medicine and Dentistry, University of the Basque Country/Euskal Herriko Unibertsitatea, Leioa, Spain
| | - María Luisa Gainza
- Department of Dental Surgery, Faculty of Dental Surgery, University of Malta, Malta
| | - Elena Eraso
- Department of Immunology, Microbiology and Parasitology, Unidad de formación e investigación multidisciplinar "Microbios y Salud" (UFI 11/25), Faculty of Medicine and Dentistry, University of the Basque Country/Euskal Herriko Unibertsitatea, Leioa, Spain
| | - Amelia Acha-Sagredo
- Department of Stomatology II, Unidad de formación e investigación multidisciplinar "Microbios y Salud" (UFI 11/25), Faculty of Medicine and Dentistry, University of the Basque Country/Euskal Herriko Unibertsitatea, Leioa, Spain
| | - José Manuel Aguirre-Urizar
- Department of Stomatology II, Unidad de formación e investigación multidisciplinar "Microbios y Salud" (UFI 11/25), Faculty of Medicine and Dentistry, University of the Basque Country/Euskal Herriko Unibertsitatea, Leioa, Spain
| |
Collapse
|
9
|
Sangaré I, Sirima C, Bamba S, Zida A, Cissé M, Bazié WW, Sanou S, Dao B, Menan H, Guiguemdé RT. Prevalence of vulvovaginal candidiasis in pregnancy at three health centers in Burkina Faso. J Mycol Med 2017; 28:186-192. [PMID: 28939305 DOI: 10.1016/j.mycmed.2017.08.006] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2017] [Revised: 08/10/2017] [Accepted: 08/18/2017] [Indexed: 11/27/2022]
Abstract
INTRODUCTION Pregnant women are more susceptible to vaginal colonization and infection by yeast. The role of Candida colonization in the occurrence of preterm birth is well established. The knowledge of local epidemiology and identification of risk factors for preterm birth is important for the prevention and management strategies. The purpose of the study was to determine the prevalence of Candida sp. in vaginal swabs of pregnant women. METHODS Pregnant women attending routine antenatal visits in three primary health centres in Bobo-Dioulasso (Burkina Faso) were enrolled into a cross-sectional study carried out from February to April 2015. Vaginal swabs samples were taken from participants after obtaining oral consent. The swabs were inoculated into Sabouraud's glucose agar supplemented with chloramphenicol and incubated at 37°C for 24 to 48hours under aerobic conditions in order to perform fungal culture. The identification of the Candida species was done by culture on HiCrome Candida Differential Agar at 35°C for 48h for production of species-specific colors. RESULTS A total of 229 pregnant women were included. The prevalence of vulvovaginal candidiasis (VVC) was 22.71%, (95% CI [17.45-28.69]). Candida albicans accounted for 40.39% and non-Candida albicans species for 59.61% of the isolates, with mainly C. glabrata (32.69%), C. tropicalis (15.38%) and C. krusei (11.54%). CONCLUSIONS This study revealed a high prevalence of non-C. albicans species. The syndromic management guidelines for VVC in Burkina Faso will be revised to include a specific protocol for pregnant women.
Collapse
Affiliation(s)
- I Sangaré
- Institut supérieur des sciences de la santé, université Nazi Boni, 01 BP 1091, Bobo-Dioulasso, Burkina Faso; Département des laboratoires, CHU Souro Sanou, Bobo-Dioulasso, Burkina Faso.
| | - C Sirima
- Centre Muraz, Bobo-Dioulasso, Burkina Faso.
| | - S Bamba
- Institut supérieur des sciences de la santé, université Nazi Boni, 01 BP 1091, Bobo-Dioulasso, Burkina Faso; Département des laboratoires, CHU Souro Sanou, Bobo-Dioulasso, Burkina Faso.
| | - A Zida
- CHU Yalgado Ouédraogo, Ouagadougou, Burkina Faso.
| | - M Cissé
- Institut supérieur des sciences de la santé, université Nazi Boni, 01 BP 1091, Bobo-Dioulasso, Burkina Faso; Centre Muraz, Bobo-Dioulasso, Burkina Faso.
| | - W W Bazié
- Centre Muraz, Bobo-Dioulasso, Burkina Faso.
| | - S Sanou
- Centre Muraz, Bobo-Dioulasso, Burkina Faso.
| | - B Dao
- Institut supérieur des sciences de la santé, université Nazi Boni, 01 BP 1091, Bobo-Dioulasso, Burkina Faso; Jhpiego, Baltimore, United States.
| | - H Menan
- Unité de formation et de recherche en sciences pharmaceutiques et biologiques et médicales, université Félix Houphouet Boigny, Abidjan, Côte d'Ivoire.
| | - R T Guiguemdé
- Institut supérieur des sciences de la santé, université Nazi Boni, 01 BP 1091, Bobo-Dioulasso, Burkina Faso.
| |
Collapse
|
10
|
De-la-Torre J, Ortiz-Samperio ME, Marcos-Arias C, Marichalar-Mendia X, Eraso E, Echebarria-Goicouria MÁ, Aguirre-Urizar JM, Quindós G. In Vitro Antifungal Susceptibility of Oral Candida Isolates from Patients Suffering from Caries and Chronic Periodontitis. Mycopathologia 2017; 182:471-485. [PMID: 28124220 DOI: 10.1007/s11046-017-0112-1] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2016] [Accepted: 01/09/2017] [Indexed: 12/19/2022]
Abstract
Caries and chronic periodontitis are common oral diseases where a higher Candida colonization is reported. Antifungal agents could be adjuvant drugs for the therapy of both clinical conditions. The aim of the current study has been to evaluate the in vitro activities of conventional and new antifungal drugs against oral Candida isolates from patients suffering from caries and/or chronic periodontitis. In vitro activities of amphotericin B, fluconazole, itraconazole, miconazole, nystatin, posaconazole and voriconazole against 126 oral Candida isolates (75 Candida albicans, 18 Candida parapsilosis, 11 Candida dubliniensis, six Candida guilliermondii, five Candida lipolytica, five Candida glabrata, four Candida tropicalis and two Candida krusei) from 61 patients were tested by the CLSI M27-A3 method. Most antifungal drugs were highly active, and resistance was observed in less than 5% of tested isolates. Miconazole was the most active antifungal drug, being more than 98% of isolates susceptible. Fluconazole, itraconazole, and the new triazoles, posaconazole and voriconazole, were also very active. Miconazole, fluconazole and voriconazole have excellent in vitro activities against all Candida isolates and could represent suitable treatment for a hypothetically adjunctive therapy of caries and chronic periodontitis.
Collapse
Affiliation(s)
- Janire De-la-Torre
- Laboratorio de Micología Médica, Departamento de Inmunología, Microbiología y Parasitología, UFI 11/25, Facultad de Medicina y Enfermería, Universidad del País Vasco-Euskal Herriko Unibertsitatea, Apartado 699, 48080, Bilbao, Spain
- Unidad de Medicina Bucal, Servicio Clínica Odontológica, Departamento de Estomatología II, UFI 11/25, Facultad de Medicina y Enfermería, Universidad del País Vasco-Euskal Herriko Unibertsitatea, Bilbao, Spain
| | - María Esther Ortiz-Samperio
- Laboratorio de Micología Médica, Departamento de Inmunología, Microbiología y Parasitología, UFI 11/25, Facultad de Medicina y Enfermería, Universidad del País Vasco-Euskal Herriko Unibertsitatea, Apartado 699, 48080, Bilbao, Spain
| | - Cristina Marcos-Arias
- Laboratorio de Micología Médica, Departamento de Inmunología, Microbiología y Parasitología, UFI 11/25, Facultad de Medicina y Enfermería, Universidad del País Vasco-Euskal Herriko Unibertsitatea, Apartado 699, 48080, Bilbao, Spain
| | - Xabier Marichalar-Mendia
- Unidad de Medicina Bucal, Servicio Clínica Odontológica, Departamento de Estomatología II, UFI 11/25, Facultad de Medicina y Enfermería, Universidad del País Vasco-Euskal Herriko Unibertsitatea, Bilbao, Spain
| | - Elena Eraso
- Laboratorio de Micología Médica, Departamento de Inmunología, Microbiología y Parasitología, UFI 11/25, Facultad de Medicina y Enfermería, Universidad del País Vasco-Euskal Herriko Unibertsitatea, Apartado 699, 48080, Bilbao, Spain
| | - María Ángeles Echebarria-Goicouria
- Unidad de Medicina Bucal, Servicio Clínica Odontológica, Departamento de Estomatología II, UFI 11/25, Facultad de Medicina y Enfermería, Universidad del País Vasco-Euskal Herriko Unibertsitatea, Bilbao, Spain
| | - José Manuel Aguirre-Urizar
- Unidad de Medicina Bucal, Servicio Clínica Odontológica, Departamento de Estomatología II, UFI 11/25, Facultad de Medicina y Enfermería, Universidad del País Vasco-Euskal Herriko Unibertsitatea, Bilbao, Spain
| | - Guillermo Quindós
- Laboratorio de Micología Médica, Departamento de Inmunología, Microbiología y Parasitología, UFI 11/25, Facultad de Medicina y Enfermería, Universidad del País Vasco-Euskal Herriko Unibertsitatea, Apartado 699, 48080, Bilbao, Spain.
| |
Collapse
|
11
|
Stefaniuk E, Baraniak A, Fortuna M, Hryniewicz W. Usefulness of CHROMagar Candida Medium, Biochemical Methods--API ID32C and VITEK 2 Compact and Two MALDI-TOF MS Systems for Candida spp. Identification. Pol J Microbiol 2016; 65:111-4. [PMID: 27282002 DOI: 10.5604/17331331.1197283] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
This study was conducted to compare of the yeasts identification results obtained with two new systems using the MALDI-TOF MS technique with the ones obtained using the routine identification methods of Candida spp. in clinical microbiology laboratories. All 124 Candida spp. isolates were recovered from the routine examination of clinical specimens in microbiological laboratories and collected in the Centre of Quality Control in Microbiology in Warsaw (Poland). Our findings confirm the high agreement (98%) of fungal identification using the standard, biochemistry laboratory methods and mass spectrometry technique.
Collapse
|